Stock futures lost ground Thursday morning ahead of the release of closely watched economic indicators, one day after major indexes posted their first gains of the week following a ...
Stock futures are pointing to a higher open on Tuesday as the market stabilizes after a massive sell-off in technology shares sent major indexes to their biggest losses of the year yesterday.
Perhaps the most popular stock index in the world, the Dow Jones Industrial Average tracks the performance of 30 prominent stocks that investors trade most often. Are futures riskier than options?
US stocks tanked to session lows on Thursday after more tariff whiplash from the Trump administration. The Dow Jones ...
The Dow has always been flawed ... it mostly matched the broader market. No longer. Far from tracking the S&P 500 index of the top U.S. companies, the Dow Jones Industrial Average for the past ...
"While tariff adjustments may provide near-term relief, global demand uncertainties and rising supply levels suggest that crude oil prices could remain under pressure, limiting the potential for a ...
2d
24/7 Wall St. on MSNBaby Boomers, Don't Let a Stock Market Crash Ruin Everything: 5 Ultra-Safe Dividend StocksFor baby boomers, ultra-safe dividend stocks like these five that can add passive income streams to Social Security benefits.
Nvidia reported its fourth-quarter results after Wednesday's closing bell. Investors and analysts have focused on early sales ...
The Dow Jones Industrial Average (DJIA) dropped today alongside the release of the January Consumer Price Index (CPI) report. That’s due to inflation during the month increasing more than ...
Stock futures rebound, but recession fears loom. Can the S&P 500 sustain gains, or is this just another selling opportunity?
The Dow Jones Industrial Average (DJIA) is down today as investors absorb the latest economic data. That includes a manufacturing slip compared to January, but the PMI remains high enough to ...
Beam Therapeutics shares were 14% lower, at $24.60, after the company priced an underwritten offering with proceeds of $500 million. The biotechnology company said it is offering 16.2 million shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results